Galera Therapeutics, Inc. cotiza a 16.28 USD y tiene una capitalización bursátil de $3.4B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly r…
| Métrica | GRTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | 3750.6% | -40.4% | +3791.0% |
| ROA | 2071.3% | -32.0% | +2103.3% |
| Current Ratio | 11.00 | 2.84 | +8.16 |
| Debt / Equity | — | 0.28 | — |